Keywords
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Ardati, K. O., M. C. Thirumoorthi, et al. (1979). “Intravenous trimethoprim-sulfamethoxazole in the treatment of serious infections in children.” J Pediatr 95(5 Pt 1): 801–806.
Ardura M, I., Mejias A et al. (2007). “Daptomycin therapy for invasive Gram-positive bacterial infections in children.” Pediatr Infect Dis J 26(12): 1128–1132.
Arnold, S. R., D. Elias, et al. (2006). “Changing patterns of acute hematogenous osteomyelitis and septic arthritis: emergence of community-associated methicillin-resistant Staphylococcus aureus.” J Pediatr Orthop 26(6): 703–708.
Bocchini, C. E., K. G. Hulten, et al. (2006). “Panton-Valentine leukocidin genes are associated with enhanced inflammatory response and local disease in acute hematogenous Staphylococcus aureus osteomyelitis in children.” Pediatrics 117(2): 433–440.
Bradley, J. S., S. L. Kaplan, et al. (1998). “Pediatric pneumococcal bone and joint infections. The Pediatric Multicenter Pneumococcal Surveillance Study Group (PMPSSG).” Pediatrics 102(6): 1376–1382.
Bryson, Y. J., J. D. Connor, et al. (1979). “High-dose oral dicloxacillin treatment of acute staphylococcal osteomyelitis in children.” J Pediatr 94(4): 673–675.
Burnett, M. W., J. W. Bass, et al. (1998). “Etiology of osteomyelitis complicating sickle cell disease.” Pediatrics 101(2): 296–297.
Carpenter, C. F. and H. F. Chambers (2004). “Daptomycin: another novel agent for treating infections due to drug-resistant gram-positive pathogens.” Clin Infect Dis 38(7): 994–1000.
Chen, C. J., C. H. Chiu, et al. (2007). “Experience With Linezolid Therapy in Children With Osteoarticular Infections.” Pediatr Infect Dis J 26(11): 985–988.
Chometon, S., Y. Benito, et al. (2007). “Specific real-time polymerase chain reaction places Kingella kingae as the most common cause of osteoarticular infections in young children.” Pediatr Infect Dis J 26(5): 377–381.
Chung, T. (2002). “Magnetic resonance imaging in acute osteomyelitis in children.” Pediatr Infect Dis J 21(9): 869–870.
Connolly, L. P., S. A. Connolly, et al. (2002). “Acute hematogenous osteomyelitis of children: assessment of skeletal scintigraphy-based diagnosis in the era of MRI.” J Nucl Med 43(10): 1310–1316.
Crary, S. E., G. R. Buchanan, et al. (2006). “Venous thrombosis and thromboembolism in children with osteomyelitis.” J Pediatr 149(4): 537–541.
Darville, T. and R. F. Jacobs (2004). “Management of acute hematogenous osteomyelitis in children.” Pediatr Infect Dis J 23(3): 255–257.
Dich, V. Q., J. D. Nelson, et al. (1975). “Osteomyelitis in infants and children. A review of 163 cases.” Am J Dis Child 129(11): 1273–1278.
Dohin, B., Y. Gillet, et al. (2007). “Pediatric Bone and Joint Infections Caused by Panton-Valentine Leukocidin-Positive Staphylococcus aureus.” Pediatr Infect Dis J 26(11): 1042–1048.
Dubey, L., K. Krasinski, et al. (1988). “Osteomyelitis secondary to trauma or infected contiguous soft tissue.” Pediatr Infect Dis J 7(1): 26–34.
Falagas, M. E., Siempos, II, et al. (2007). “Linezolid for the treatment of adults with bone and joint infections.” Int J Antimicrob Agents 29(3): 233–239.
Fernandez, M., C. L. Carrol, et al. (2000). “Discitis and vertebral osteomyelitis in children: an 18-year review.” Pediatrics 105(6): 1299–304.
Floyed, R. L. and R. W. Steele (2003). “Culture-negative osteomyelitis.” Pediatr Infect Dis J 22(8): 731–736.
Fowler, V. G., Jr., H. W. Boucher, et al. (2006). “Daptomycin versus standard therapy for bacteremia and endocarditis caused by Staphylococcus aureus.” N Engl J Med 355(7): 653–665.
Frank, A. L., J. F. Marcinak, et al. (2002). “Clindamycin treatment of methicillin-resistant Staphylococcus aureus infections in children.” Pediatr Infect Dis J 21(6): 530–534.
Gerson, S. L., S. L. Kaplan, et al. (2002). “Hematologic effects of linezolid: summary of clinical experience.” Antimicrob Agents Chemother 46(8): 2723–2726.
Gonzalez, B. E., K. G. Hulten, et al. (2005). “Pulmonary manifestations in children with invasive community-acquired Staphylococcus aureus infection.” Clin Infect Dis 41(5): 583–590.
Gonzalez, B. E., G. Martinez-Aguilar, et al. (2005). “Severe Staphylococcal sepsis in adolescents in the era of community-acquired methicillin-resistant Staphylococcus aureus.” Pediatrics 115(3): 642–648.
Gonzalez, B. E., J. Teruya, et al. (2006). “Venous thrombosis associated with staphylococcal osteomyelitis in children.” Pediatrics 117(5): 1673–1679.
Ibia, E. O., M. Imoisili, et al. (2003). “Group A beta-hemolytic streptococcal osteomyelitis in children.” Pediatrics 112(1 Pt 1): e22–26.
Jacobs, R. F., R. E. McCarthy, et al. (1989). “Pseudomonas osteochondritis complicating puncture wounds of the foot in children: a 10-year evaluation.” J Infect Dis 160(4): 657–661.
Kaplan, S. L. (2005). “Osteomyelitis in children.” Infect Dis Clin North Am 19(4): 787–797, vii.
Kaplan, S. L., J. G. Deville, et al. (2003). “Linezolid versus vancomycin for treatment of resistant Gram-positive infections in children.” Pediatr Infect Dis J 22(8): 677–686.
Kaplan, S. L., E. O. Mason, Jr., et al. (1982). “Clindamycin versus nafcillin or methicillin in the treatment of Staphylococcus aureus osteomyelitis in children.” South Med J 75(2): 138–142.
Karmazyn, B., R. T. Loder, et al. (2007). “The role of pelvic magnetic resonance in evaluating nonhip sources of infection in children with acute nontraumatic hip pain.” J Pediatr Orthop 27(2): 158–164.
Karwowska, A., H. D. Davies, et al. (1998). “Epidemiology and outcome of osteomyelitis in the era of sequential intravenous-oral therapy.” Pediatr Infect Dis J 17(11): 1021–1026.
Kearns GL, J. R., Jafri HS, Hong EF and Benziger BD (2007). Pharmacokinetics of daptomycin in pediatric patients. Pediatric Academic Societies' Annual Meeting. Toronto.
Krogstad (2004). Osteomyelitis and septic arthritis. Textbook of Pediatric Infectious Diseases. J. RD Feigin, GJ Demmler, SL Kaplan Philadelphia, Saunders: 713–736.
Lamp, K. C., L. V. Friedrich, et al. (2007). “Clinical experience with daptomycin for the treatment of patients with osteomyelitis.” Am J Med 120(10 Suppl 1): S13–S20.
Le Saux, N., A. Howard, et al. (2002). “Shorter courses of parenteral antibiotic therapy do not appear to influence response rates for children with acute hematogenous osteomyelitis: a systematic review.” BMC Infect Dis 2: 16.
Lewis, J. S., 2nd and J. H. Jorgensen (2005). “Inducible clindamycin resistance in Staphylococci: should clinicians and microbiologists be concerned?” Clin Infect Dis 40(2): 280–285.
Martinez-Aguilar, G., A. Avalos-Mishaan, et al. (2004). “Community-acquired, methicillin-resistant and methicillin-susceptible Staphylococcus aureus musculoskeletal infections in children.” Pediatr Infect Dis J 23(8): 701–706.
Martinez-Aguilar, G., W. A. Hammerman, et al. (2003). “Clindamycin treatment of invasive infections caused by community-acquired, methicillin-resistant and methicillin-susceptible Staphylococcus aureus in children.” Pediatr Infect Dis J 22(7): 593–598.
Meissner, H. C., T. Townsend, et al. (2003). “Hematologic effects of linezolid in young children.” Pediatr Infect Dis J 22(9 Suppl): S186–S192.
Moumile, K., J. Merckx, et al. (2003). “Osteoarticular infections caused by Kingella kingae in children: contribution of polymerase chain reaction to the microbiologic diagnosis.” Pediatr Infect Dis J 22(9): 837–839.
Nourse, C., M. Starr, et al. (2007). “Community-acquired methicillin-resistant Staphylococcus aureus causes severe disseminated infection and deep venous thrombosis in children: literature review and recommendations for management.” J Paediatr Child Health 43(10): 656–661.
Peltola, H., L. Unkila-Kallio, et al. (1997). “Simplified treatment of acute staphylococcal osteomyelitis of childhood. The Finnish Study Group.” Pediatrics 99(6): 846–850.
Pickering L. K., B. C., S. S. Long, J. A. McMillan (2006). Staphylococcal Infections. Red Book: 2006 Report of the Committee on Infectious Diseases. B. C. Pickering LK, Long SS, McMillan JA. Elk Grove, American academy of Pediatrics: 598–610.
Rayner, C. R., L. M. Baddour, et al. (2004). “Linezolid in the treatment of osteomyelitis: results of compassionate use experience.” Infection 32(1): 8–14.
Rifai, A. and R. Nyman (1997). “Scintigraphy and ultrasonography in differentiating osteomyelitis from bone infarction in sickle cell disease.” Acta Radiol 38(1): 139–143.
Ruebner, R., R. Keren, et al. (2006). “Complications of central venous catheters used for the treatment of acute hematogenous osteomyelitis.” Pediatrics 117(4): 1210–1215.
Ruhe, J. J., T. Monson, et al. (2005). “Use of long-acting tetracyclines for methicillin-resistant Staphylococcus aureus infections: case series and review of the literature.” Clin Infect Dis 40(10): 1429–1434.
Sdougkos, G., V. Chini, et al. (2007). “Methicillin-resistant Staphylococcus aureus producing Panton-Valentine leukocidin as a cause of acute osteomyelitis in children.” Clin Microbiol Infect 13(6): 651–654.
Unkila-Kallio, L., M. J. Kallio, et al. (1994). “Serum C-reactive protein, erythrocyte sedimentation rate, and white blood cell count in acute hematogenous osteomyelitis of children.” Pediatrics 93(1): 59–62.
Yagupsky, P. (2004). “Kingella kingae infections of the skeletal system in children: diagnosis and therapy.” Expert Rev Anti Infect Ther 2(5): 787–794.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2009 Springer Science+Business Media, LLC
About this chapter
Cite this chapter
Kaplan, S.L. (2009). Challenges in the Evaluation and Management of Bone and Joint Infections and the Role of New Antibiotics for Gram Positive Infections. In: Finn, A., Curtis, N., Pollard, A. (eds) Hot Topics in Infection and Immunity in Children V. Advances in Experimental Medicine and Biology, vol 634. Springer, New York, NY. https://doi.org/10.1007/978-0-387-79838-7_10
Download citation
DOI: https://doi.org/10.1007/978-0-387-79838-7_10
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-0-387-79837-0
Online ISBN: 978-0-387-79838-7
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)